Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Feb;80(3):835-9.
doi: 10.1073/pnas.80.3.835.

Receptor for transferrin may be a "target" structure for natural killer cells

Receptor for transferrin may be a "target" structure for natural killer cells

L Vodinelich et al. Proc Natl Acad Sci U S A. 1983 Feb.

Abstract

Human transferrin receptors detected by monoclonal antibody OKT9 appear to be well expressed on cell types known to provide sensitive targets for natural killer (NK) cells. The possibility that transferrin receptors are recognized by NK effector cells has been investigated by three series of experiments: (i) analysis of the correlation between sensitivity to natural killing and the proportion of transferrin receptor-positive cells in different cell lines, (ii) study of the relationship between levels of transferrin receptor expression in cell lines and their capacity to competitively inhibit recognition and killing of the target cell K562 by NK cells, and (iii) comparison of affinity-purified soluble proteolytic fragments of the transferrin receptor and HLA-A, -B molecules for their ability to inhibit the natural killing effect. The data indicate that the transferrin receptor can provide a "target" structure for NK cells. Because transferrin receptors are ubiquitously expressed on normal and malignant proliferating cells, these observations have interesting implications for the possible function of NK cells in vivo.

PubMed Disclaimer

References

    1. J Natl Cancer Inst. 1974 Feb;52(2):345-52 - PubMed
    1. Int J Cancer. 1975 Aug 15;16(2):216-29 - PubMed
    1. J Natl Cancer Inst. 1977 Jul;59(1):77-82 - PubMed
    1. Int J Cancer. 1977 Jul 15;20(1):93-103 - PubMed
    1. Eur J Immunol. 1977 Sep;7(9):655-63 - PubMed